| Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report … JJM Van Dongen, AW Langerak, M Brüggemann, PAS Evans, M Hummel, ... Leukemia 17 (12), 2257-2317, 2003 | 3604 | 2003 |
| International network of cancer genome projects Data coordination centre Kasprzyk (Leader) Arek 1 Stein (Leader) Lincoln D ... Nature 464 (7291), 993-998, 2010 | 2251 | 2010 |
| Standardization and quality control studies of ‘real-time’quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection … J Gabert, E Beillard, VHJ Van der Velden, W Bi, D Grimwade, ... Leukemia 17 (12), 2318-2357, 2003 | 1904 | 2003 |
| Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia XS Puente, M Pinyol, V Quesada, L Conde, GR Ordóñez, N Villamor, ... Nature 475 (7354), 101-105, 2011 | 1875 | 2011 |
| Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease JJM Van Dongen, EA Macintyre, JA Gabert, E Delabesse, V Rossi, ... Leukemia 13 (12), 1901-1928, 1999 | 1535 | 1999 |
| Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia V Quesada, L Conde, N Villamor, GR Ordóñez, P Jares, L Bassaganyas, ... Nature genetics 44 (1), 47-52, 2012 | 1235 | 2012 |
| Non-coding recurrent mutations in chronic lymphocytic leukaemia XS Puente, S Beà, R Valdés-Mas, N Villamor, J Gutiérrez-Abril, ... Nature 526 (7574), 519-524, 2015 | 984 | 2015 |
| Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA … MA Sanz, FL Coco, G Martın, G Avvisati, C Rayón, T Barbui, ... Blood, The Journal of the American Society of Hematology 96 (4), 1247-1253, 2000 | 813 | 2000 |
| Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA … MA Sanz, G Martín, M González, A León, C Rayón, C Rivas, D Colomer, ... Blood 103 (4), 1237-1243, 2004 | 609 | 2004 |
| Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma J Flores-Montero, L Sanoja-Flores, B Paiva, N Puig, O García-Sánchez, ... Leukemia 31 (10), 2094-2103, 2017 | 586 | 2017 |
| A Modified AIDA Protocol With Anthracycline-Based Consolidation Results in High Antileukemic Efficacy and Reduced Toxicity in Newly Diagnosed PML/RAR-Positive Acute … MA Sanz, G Martı́n, C Rayón, J Esteve, M González, J Dı́az-Mediavilla, ... Blood, The Journal of the American Society of Hematology 94 (9), 3015-3021, 1999 | 541 | 1999 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 534* | 2021 |
| Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma J Martinez-Lopez, JJ Lahuerta, F Pepin, M González, S Barrio, R Ayala, ... Blood, The Journal of the American Society of Hematology 123 (20), 3073-3079, 2014 | 496 | 2014 |
| Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics R Garcıa-Sanz, A Orfao, M Gonzalez, MD Tabernero, J Bladé, MJ Moro, ... Blood, The Journal of the American Society of Hematology 93 (3), 1032-1037, 1999 | 454 | 1999 |
| Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment … JF San Miguel, MB Vidriales, C López-Berges, J Dıaz-Mediavilla, ... Blood, The Journal of the American Society of Hematology 98 (6), 1746-1751, 2001 | 429 | 2001 |
| Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin J De La Serna, P Montesinos, E Vellenga, C Rayón, R Parody, A León, ... Blood, The Journal of the American Society of Hematology 111 (7), 3395-3402, 2008 | 426 | 2008 |
| Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and … MJ Pongers-Willemse, T Seriu, F Stolz, E d’Aniello, P Gameiro, P Pisa, ... Leukemia 13 (1), 110-118, 1999 | 420 | 1999 |
| Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome … P Montesinos, JM Bergua, E Vellenga, C Rayón, R Parody, J De La Serna, ... Blood, The Journal of the American Society of Hematology 113 (4), 775-783, 2009 | 383 | 2009 |
| Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia F Nadeu, J Delgado, C Royo, T Baumann, T Stankovic, M Pinyol, P Jares, ... Blood, The Journal of the American Society of Hematology 127 (17), 2122-2130, 2016 | 365 | 2016 |
| Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants S Beà, M Ribas, JM Hernández, F Bosch, M Pinyol, L Hernández, ... Blood, The Journal of the American Society of Hematology 93 (12), 4365-4374, 1999 | 361 | 1999 |
